Patent · US Active

Inhibitors of indoleamine 2,3-dioxygenase (IDO)

US9675571B2 · kind B2 · utility

2Cited by

0References

11Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

James Aaron Balog · Lambertville, US
Audris Huang · Princeton, US
Bin Chen · Pennington, US
Libing Chen · Newtown, US
Steven P. Seitz · Swarthmore, US
Amy C. Hart · Ewing, US
Jay A. Markwalder · New London, US

Key dates

Filing date	Mar 12, 2014
Grant date	Jun 13, 2017
Priority date	—
Expiry date	Mar 12, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.